Cover Image
Read Now

Breakthrough business models drug development for rare and neglected diseases and individualized therapies : workshop summary

"The Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop on June 23, 2008, titled "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies." The purpose of the workshop was to exp...

Full description

Bibliographic Details
Main Author: Wizemann, Theresa M.
Corporate Author: Institute of Medicine (U.S.) Forum on Drug Discovery, Development, and Translation
Other Authors: Robinson, Sally, Giffin, Robert B.
Format: eBook
Language:English
Published: Washington, D.C. National Academies Press c2009, 2009
Subjects:
Research / Trends
Research / Economics
United States
Models, Economic
Orphan Drug Production / Economics
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02274nam a2200361 u 4500
001 EB000942565
003 EBX01000000000000000736155
005 00000000000000.0
007 tu|||||||||||||||||||||
008 150223 r ||| eng
020 |a 9780309120883 
020 |a 0309120888 
050 4 |a RA401.A3 
100 1 |a Wizemann, Theresa M. 
245 0 0 |a Breakthrough business models  |h Elektronische Ressource  |b drug development for rare and neglected diseases and individualized therapies : workshop summary  |c Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies 
260 |a Washington, D.C.  |b National Academies Press  |c c2009, 2009 
300 |a xviii, 131 p.  |b ill.  |c 23 cm 
505 0 |a Include bibliographical references (p. 104-105) 
505 0 |a Introduction and overview -- Current model for financing drug development: from concept through approval -- The Food and Drug Administration's Orphan Drug Program -- Diverse funding models -- Strategies for facilitating sharing of research materials and data -- Strategies of navigation intellectual property -- Strategies for facilitating clinical trials -- Summary 
653 |a Research / trends 
653 |a Research / economics 
653 |a United States 
653 |a Models, Economic 
653 |a Orphan Drug Production / economics 
700 1 |a Robinson, Sally 
700 1 |a Giffin, Robert B. 
710 2 |a Institute of Medicine (U.S.)  |b Forum on Drug Discovery, Development, and Translation 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK50977  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
856 4 0 |u http://search.nap.edu/nap-cgi/de.cgi?term=0309120888  |3 Volltext  |n Provider site  |3 Volltext 
082 0 |a 330 
520 |a "The Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop on June 23, 2008, titled "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies." The purpose of the workshop was to explore innovative strategies for orphan drug development" 

Similar Items